Enox Biopharma
Nitric Oxide Embedding for Medical Devices
Company Overview
Snapshot
Founded in April 2007 by Dan Sadeh Hochstadter and Yossef Av-Gay, Enox Biopharma operates with 1–10 employees. The company received European patent approval in June 2011 for its technology related to administering therapeutic agents.
Business overview
Enox Biopharma is a biotechnology company specializing in embedding nitric oxide (NO) into polymer-based medical devices to render them antimicrobial. The company's core technology involves a method for impregnating these devices with NO, which is then released over extended periods to provide antimicrobial activity. Enox Biopharma focuses on developing products for medical devices such as urinary catheters, endotracheal tubes, and central venous catheters, targeting the healthcare and life sciences sectors to address high rates of infection associated with temporary medical device insertions.
Strategic signal
In October 2020, Enox Biopharma ceased to operate. This indicates a complete halt in company activities, suggesting a significant and permanent shift in its operational status and market presence.
Log in to access full profile ›Company Intelligence Q&A
- What is Enox Biopharma's primary focus?
- Enox Biopharma focuses on developing antimicrobial medical devices by embedding nitric oxide into polymer-based materials, targeting devices like urinary catheters and endotracheal tubes to prevent infections.
- When was Enox Biopharma founded and by whom?
- Enox Biopharma was founded in April 2007 by Dan Sadeh Hochstadter and Yossef Av-Gay.
- What was a significant intellectual property milestone for Enox Biopharma?
- In June 2011, Enox Biopharma received European patent approval for its 'Device and Method for Administering Therapeutic Agents,' specifically for the release of low molecular weight antimicrobial agents like nitric oxide from medical devices.
- What is the current operational status of Enox Biopharma?
- Enox Biopharma ceased to operate in October 2020, with no activity in the Israeli registrar or employees operating in Israel according to LinkedIn.
- What types of medical devices does Enox Biopharma's technology aim to improve?
- Enox Biopharma's product development focuses on devices such as urinary catheters, endotracheal tubes, central venous catheters, and tympanostomy tubes, which are often associated with high rates of infection.